RBC Bioscience

RBC Bioscience FCF Growth

The Year-over-Year Free Cash Flow Growth of RBC Bioscience (6848.TWO) as of Nov 6, 2026 is 576.26 %. In the previous year, Year-over-Year Free Cash Flow Growth was 295.82 % — a change of 94.80% (higher).

FCF Growth

576.26 %

YoY

94.80%

Last updated:

Year-over-Year Free Cash Flow Growth of RBC Bioscience is 2024 576.26 % . Year-over-Year Free Cash Flow Growth of RBC Bioscience was 2023 295.82 % . It decreases by 94.80% higher compared to the previous year.

The RBC Bioscience FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2019
147.01 TWD
Jan 1, 2020
180.87 TWD
Jan 1, 2021
-644.77 TWD
Jan 1, 2022
99.28 TWD
Jan 1, 2023
295.82 TWD
Jan 1, 2024
576.26 TWD
The RBC Bioscience FCF Growth history
YEARFCF GrowthYoY
576.26 %+94.80%
295.82 %+197.98%
99.28 %-115.40%
-644.77 %-456.48%
180.87 %+23.04%
147.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Year-over-Year Free Cash Flow Growth of RBC Bioscience is 576.26 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — RBC Bioscience

All Key Metrics — RBC Bioscience